Evidence-Based Medicine Guidelines
Neo-adjuvant and adjuvant hormone therapy for localised and locally advanced prostate cancer
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Neo-adjuvant and Adjuvant Hormone Therapy for Localised and Locally Advanced Prostate Cancer." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/451412/all/Neo_adjuvant_and_adjuvant_hormone_therapy_for_localised_and_locally_advanced_prostate_cancer.
Neo-adjuvant and adjuvant hormone therapy for localised and locally advanced prostate cancer. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/EBMG/451412/all/Neo_adjuvant_and_adjuvant_hormone_therapy_for_localised_and_locally_advanced_prostate_cancer. Accessed May 18, 2025.
Neo-adjuvant and adjuvant hormone therapy for localised and locally advanced prostate cancer. (2025). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/451412/all/Neo_adjuvant_and_adjuvant_hormone_therapy_for_localised_and_locally_advanced_prostate_cancer
Neo-adjuvant and Adjuvant Hormone Therapy for Localised and Locally Advanced Prostate Cancer [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. [cited 2025 May 18]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/451412/all/Neo_adjuvant_and_adjuvant_hormone_therapy_for_localised_and_locally_advanced_prostate_cancer.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Neo-adjuvant and adjuvant hormone therapy for localised and locally advanced prostate cancer
ID - 451412
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/451412/all/Neo_adjuvant_and_adjuvant_hormone_therapy_for_localised_and_locally_advanced_prostate_cancer
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
